Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.58 |
| ▸ | NOS1 | P29475 | 7/20 | 0.42 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.42 |
| ▸ | NOS2 | P35228 | 7/20 | 0.41 |
| ▸ | NOS3 | P29474 | 5/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ARG2 | P78540 | 4/20 | 0.41 |
| ▸ | ARG1 | P05089 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ornithine SCHEMBL53033 | 1.00 | GSR (0.58) | GSRNOS1DDAH1NOS2NOS3 | |
| Lysine SCHEMBL3821051 | 0.92 | GSR (0.62) | GSRNOS1DDAH1NOS2NOS3 | |
| Lysine SCHEMBL3821052 | 0.92 | GSR (0.62) | GSRNOS1DDAH1NOS2NOS3 | |
| Ornithine Aketoglutarate SCHEMBL3000503 | 0.84 | GSR (0.64) | GSRNOS1DDAH1NOS2NOS3 | |
| Ornithine SCHEMBL6757036 | 0.84 | GSR (0.64) | GSRNOS1DDAH1NOS2NOS3 | |
| Ornithine SCHEMBL3000505 | 0.84 | GSR (0.64) | GSRNOS1DDAH1NOS2NOS3 | |
| Diaminopropanoic Acid SCHEMBL28533274 | 0.82 | SLC1A3 (0.39) | GSRCYP1A2 | |
| Ornithine Aketoglutarate SCHEMBL28452040 | 0.81 | GSR (0.78) | GSRNOS1DDAH1NOS2NOS3 | |
| Ornithine SCHEMBL3443860 | 0.81 | GSR (0.78) | GSRNOS1DDAH1NOS2NOS3 | |
| Ornithine SCHEMBL624782 | 0.81 | GSR (0.86) | GSRNOS1NOS2NOS3CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1614 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114015726-B | Delivery, use and therapeutic application of CRISPR-CAS systems and compositions for targeting disorders and diseases with viral components | 布罗德研究所有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-113425857-B | Delivery and use of CRISPR-CAS systems, vectors and compositions for liver targeting and treatment | 布罗德研究所有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-112840030-B | Method for reducing nitrosamine content in tobacco using constitutive high affinity cationic efflux proteins | 英美烟草(投资)有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-113227366-B | Method for regulating alkaloid content of plant | 英美烟草(投资)有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-110312805-B | Method of | 肯塔基大学研究基金会 | 2025-04-29 | — | — | CN | disclosed |
| CN-113272434-B | Methods and means for modifying alkaloid content in plants | 英美烟草(投资)有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-110959039-B | Novel CAS13B ortholog CRISPR enzymes and systems | 博德研究所 | 2025-03-14 | — | — | CN | disclosed |
| CN-113939201-B | BZIP transcription factors regulate the conversion of nicotine to nornicotine and reduce the levels of Tobacco Specific Nitrosamine (TSNA) precursors | R·J·雷诺烟草公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119584864-A | Improved enzymatic modification of phospholipids in food products | 国际N&H丹麦有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-113614235-B | Method for reducing alkaloid content of tobacco plants | 英美烟草(投资)有限公司 | 2025-02-11 | — | — | CN | disclosed |
| WO-2001077380-A2 | METHOD FOR PREDICTING PREDISPOSITION TO A DISEASE ASSOCIATED WITH MUTATIONS IN A RPGR GENE | MEDICAL RESEARCH COUNCIL (GB) | 2001-10-18 | — | — | WO | disclosed |
| EP-1135410-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | Cyclacel Limited (GB) | 2001-09-26 | — | — | EP | disclosed |
| EP-1118858-A2 | Assay method | Pfizer Limited (GB) | 2001-07-25 | — | — | EP | disclosed |
| EP-1108360-A1 | Method of improving dough and bread quality | DANISCO A/S (DK) | 2001-06-20 | — | — | EP | disclosed |
| WO-2001039602-A1 | METHOD OF IMPROVING DOUGH AND BREAD QUALITY | DANISCO A/S (DK) | 2001-06-07 | — | — | WO | disclosed |
| EP-1097707-A1 | Treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| EP-1097706-A1 | Phosphodiesterase inhibitors for the treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| EP-1097719-A1 | NEP inhibitors for the treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| EP-1097718-A1 | NPY antagonists for the treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000029427-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | CYCLACEL LIMITED (GB) | 2000-05-25 | — | — | WO | disclosed |